Research and Publications

INSILICO DEVELOPMENT OF NOVEL RSK2 INHIBITORS USING DOCKING AND PHARMACOPHORE STUDIES - Accepted in EJPMR for Publication.

“Design, synthesis and biological evaluation of morpholine, piperidine and phenyl derivatives of quinazolinone as hsp90 ATPase inhibitors”
Published in EJPMR ISSN 2394-3211 Published in March 2017


“Molecular docking and pharmacophore studies of heterocyclic compounds as Heat shock protein 90 (Hsp90) Inhibitors” (Pubmed-28232775) Volume 12(3), Received April 9, 2016; Revised May 15, 2016; Accepted May 16, 2016; Published June 15,2016

"Theoretical Studies on Azaindoles as Human Aurora B kinase Inhibitors:  Docking,Pharmacophore and ADMET studies", has Published in,Interdisciplinary Sciences:Computational Life Sciences,Springer, PMID: 27981429 DOI: 10.1007/s12539-016- 0205-4

"Molecular Docking studies of Synthetic and Natural compounds against cFLIP protein in cancer" (Manuscript Number: JAPS-2016- 08-638) was accepted for publication in the Journal of Applied Pharmaceutical Science.

"Insilico discovery of human aurora b kinase inhibitors by molecular docking,pharmacophore validation and admet studies "
manuscript AJPCR/14974/16 : was accepted for publication in Asian Journal of Pharmaceutical & Clinical Research


"Synthesis, biological evaluation and molecular docking studies of novel 2-(2- cyanophenyl)-N- phenylacetamide derivatives Accepted for publication in Research on Chemical Intermediates (RINT) (manuscript number, RINT-D- 18-00098R1 Impact factor-1.369)."

"Synthesis, biological evolution and molecular docking studies of novel 1,2,3-triazole tagged 5- ((1H-indol- 3-yl)methylene)pyrimidine- 2,4,6(1H,3H,5H)-trione derivatives article (registry no.g18-008) was accepted for publication in the Russian Journal of General Chemistry Impact factor -0.553)."
Quick Contacts

+91 - 40 - 6633.1511
+91 92477.16307
+91 80199.74974
+91 97039.74974

info@averinbiotech.com
www.averinbiotech.com